Paul, Graham, Somers, Graham and Taylor, Glyn 2016. Implications for room lighting and the duration of acclimation protocols on the dosimetry of inhaled drugs in rats. Respiratory Drug Delivery 2 , pp. 327-332. |
Aljayyoussi, Ghaith, Price, Daniel F., Francombe, Danielle, Taylor, Glyn, Smith, Mathew W. ORCID: https://orcid.org/0000-0002-5697-0204, Morris, Christopher John, Edwards, Chris, Eddershaw, Peter and Gumbleton, Mark ORCID: https://orcid.org/0000-0002-7386-311X 2013. Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: A study in ex vivo lung models using chemical inhibition and genetic knockout. Journal of Pharmaceutical Sciences 102 (9) , pp. 3382-3394. 10.1002/jps.23587 |
Newman, Stephen, Bennett, William D., Biddiscombe, Martyn, Devadason, Sunalene G., Dolovich, Myrna B., Fleming, John, Haeussermann, Sabine, Kietzig, Claudius, Kuehl, Philip J., Laube, Beth L., Sommerer, Knut, Taylor, Glyn, Usmani, Omar S. and Zeman, Kirby L. 2012. Standardization of Techniques for Using Planar (2D) Imaging for Aerosol Deposition Assessment of Orally Inhaled Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery 25 (S1) , S10-S28. 10.1089/jamp.2012.1Su4 |
Devadason, Sunalene G., Chan, Hak-Kim, Haeussermann, Sabine, Kietzig, Claudius, Kuehl, Philip J., Newman, Stephen, Sommerer, Knut and Taylor, Glyn 2012. Validation of Radiolabeling of Drug Formulations for Aerosol Deposition Assessment of Orally Inhaled Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery 25 (S1) , S6-S9. 10.1089/jamp.2012.1Su3 |
Kellerman, D., Kori, S., Forst, A., Chang, J., Febbraro, S., WuTann, L., Thomas, T., Taylor, Glyn and Dodick, D. W. 2011. Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans. Cephalalgia 32 (2) , pp. 150-158. 10.1177/0333102411432299 |
Bains, Baljinder Kaur, Birchall, James Caradoc ORCID: https://orcid.org/0000-0001-8521-6924, Toon, Richard and Taylor, Glyn 2010. In vitro reporter gene transfection via plasm ID DNA delivered by metered dose inhaler. Journal of Pharmaceutical Sciences 99 (7) , pp. 3089-3099. 10.1002/jps.22085 |
Nikander, Kurt, Prince, Ivan, Coughlin, Steven, Warren, Simon J. and Taylor, Glyn 2010. Mode of breathing- tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) System affects lung deposition of Tc-99m-DTPA. Journal of Aerosol Medicine and Pulmonary Drug Delivery 23 (S1) , S37-S43. 10.1089/jamp.2009.0786 |
Hampson, Frank C., Jolliffe, Ian G., Bakhtyari, Arash, Taylor, Glyn, Sykes, John, Johnstone, Lesley M. and Dettmar, Peter W. 2010. Alginate-antacid combinations: raft formation and gastric retention studies. Drug Development and Industrial Pharmacy 36 (5) , pp. 614-623. 10.3109/03639040903388290 |
Weers, Jeffry, Metzheiser, Beth, Taylor, Glyn, Warren, Simon J., Meers, Paul and Perkins, Walter R. 2009. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. Journal of Aerosol Medicine and Pulmonary Drug Delivery 22 (2) , pp. 131-138. 10.1089/jamp.2008.0693 |
Shrewsbury, Stephen B., Cook, Robert O., Taylor, Glyn, Edwards, Ceri and Ramadan, Nabih M. 2008. Safety and pharmacokinetics of dihydroergotamine mesylate administered via a novel (Tempo™) inhaler. Headache 48 (3) , pp. 355-367. |
Bains, Baljunder Kaur, Taylor, Glyn, Toon, R. and Birchall, James Caradoc ORCID: https://orcid.org/0000-0001-8521-6924 2007. Novel nanoparticles for pulmonary gene delivery [Abstract]. Pharmacy and Pharmacology 59 (S1) , A31-A32. 10.1211/002235707781850140 |
Shrewsbury, S. B., Cook, R., Taylor, Glyn, Edwards, C. and Ramadan, N. 2007. Comparative clinical pharmacokinetics of parent drug and metabolites following inhaled dosing with dihydroergotamine mesylate via a novel system (Tempo (TM) inhaler). Headache 47 (5) , p. 754. |
Shrewsbury, S. B., Cook, R., Taylor, Glyn, Edwards, C. and Ramadan, N. 2007. Clinical safety of inhaled dihydroergotamine mesylate via a novel system (Tempo (TM) inhaler). Headache 47 (5) , pp. 753-754. |
Buggins, T. R., Dickinson, P. A. and Taylor, Glyn 2007. The effects of pharmaceutical excipients on drug disposition. Advanced Drug Delivery Reviews 59 (15) , pp. 1482-1503. 10.1016/j.addr.2007.08.017 |
Li, H.-Y., Jeans, Christopher, Birchall, James Caradoc ORCID: https://orcid.org/0000-0001-8521-6924 and Taylor, Glyn 2005. Nanoparticles for pulmonary drug delivery [Abstract]. Journal of Pharmacy and Pharmacology 57 (S1) , S20. 10.1211/002235705778248569 |
Boyd, Brooks, Noymer, Peter, Liu, Kui, Okikawa, Jerry, Hasegawa, Dave, Warren, Simon, Taylor, Glyn, Ferguson, Elizabeth, Schuster, Jeff, Farr, Stephen and Gonda, Igor 2004. Effect of Gender and Device Mouthpiece Shape on Bolus Insulin Aerosol Delivery Using the AERxPulmonary Delivery System. Pharmaceutical Research 21 (10) , pp. 1776-1782. 10.1023/B:PHAM.0000045228.32419.ba |
Warren, Simon, Taylor, Glyn, Smith, Jeffrey, Buck, Helen and Parry-Billings, Mark 2002. Gamma Scintigraphic Evaluation of a Novel Budesonide Dry Powder Inhaler Using a Validated Radiolabeling Technique. Journal of Aerosol Medicine 15 (1) , pp. 15-25. 10.1089/08942680252908548 |
Colthorpe, Paul, Fair, Stephen J., Smith, Ian J., Wyatt, David and Taylor, Glyn 1995. The Influence of Regional Deposition on the Pharmacokinetics of Pulmonary-Delivered Human Growth Hormone in Rabbits. Pharmaceutical Research 12 (3) , pp. 356-359. 10.1023/A:1016292232513 |
Farr, S. J., Rowe, A. M., Rubsamen, R. and Taylor, Glyn 1995. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler. Thorax 50 (6) , pp. 639-644. 10.1136/thx.50.6.639 |